1. Home
  2. MNKD vs UDMY Comparison

MNKD vs UDMY Comparison

Compare MNKD & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • UDMY
  • Stock Information
  • Founded
  • MNKD 1991
  • UDMY 2009
  • Country
  • MNKD United States
  • UDMY United States
  • Employees
  • MNKD N/A
  • UDMY N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • UDMY Other Consumer Services
  • Sector
  • MNKD Health Care
  • UDMY Real Estate
  • Exchange
  • MNKD Nasdaq
  • UDMY Nasdaq
  • Market Cap
  • MNKD 1.4B
  • UDMY 904.2M
  • IPO Year
  • MNKD 2004
  • UDMY 2021
  • Fundamental
  • Price
  • MNKD $4.56
  • UDMY $6.77
  • Analyst Decision
  • MNKD Buy
  • UDMY Buy
  • Analyst Count
  • MNKD 6
  • UDMY 11
  • Target Price
  • MNKD $8.92
  • UDMY $9.90
  • AVG Volume (30 Days)
  • MNKD 1.5M
  • UDMY 1.1M
  • Earning Date
  • MNKD 05-08-2025
  • UDMY 04-30-2025
  • Dividend Yield
  • MNKD N/A
  • UDMY N/A
  • EPS Growth
  • MNKD 215.86
  • UDMY N/A
  • EPS
  • MNKD 0.10
  • UDMY N/A
  • Revenue
  • MNKD $297,595,000.00
  • UDMY $790,019,000.00
  • Revenue This Year
  • MNKD $14.23
  • UDMY $2.96
  • Revenue Next Year
  • MNKD $14.56
  • UDMY $5.52
  • P/E Ratio
  • MNKD $46.04
  • UDMY N/A
  • Revenue Growth
  • MNKD 32.50
  • UDMY 5.43
  • 52 Week Low
  • MNKD $4.17
  • UDMY $5.68
  • 52 Week High
  • MNKD $7.63
  • UDMY $10.61
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 38.80
  • UDMY 48.84
  • Support Level
  • MNKD $4.42
  • UDMY $6.21
  • Resistance Level
  • MNKD $5.05
  • UDMY $7.06
  • Average True Range (ATR)
  • MNKD 0.18
  • UDMY 0.27
  • MACD
  • MNKD 0.00
  • UDMY 0.09
  • Stochastic Oscillator
  • MNKD 20.59
  • UDMY 73.02

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

Share on Social Networks: